Cargando…

Fibroblast Activation Protein Expression in Sarcomas

OBJECTIVES: Fibroblast activation protein alpha (FAP) is highly expressed by cancer-associated fibroblasts in multiple epithelial cancers. The aim of this study was to characterize FAP expression in sarcomas to explore its potential utility as a diagnostic and therapeutic target and prognostic bioma...

Descripción completa

Detalles Bibliográficos
Autores principales:	Crane, Jacquelyn N., Graham, Danielle S., Mona, Christine E., Nelson, Scott D., Samiei, Alireza, Dawson, David W., Dry, Sarah M., Masri, Marwan G., Crompton, Joseph G., Benz, Matthias R., Czernin, Johannes, Eilber, Fritz C., Graeber, Thomas G., Calais, Jeremie, Federman, Noah C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2023
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10275689/ https://www.ncbi.nlm.nih.gov/pubmed/37333052 http://dx.doi.org/10.1155/2023/2480493

Ejemplares similares

[(18)F]FDG PET/CT for evaluating early response to neoadjuvant chemotherapy in pediatric patients with sarcoma: a prospective single-center trial
por: Polverari, Giulia, et al.
Publicado: (2020)

(18)F-FLT PET/CT as a Prognostic Imaging Biomarker of Disease-Specific Survival in Patients with Primary Soft-Tissue Sarcoma
por: Crompton, Joseph G., et al.
Publicado: (2022)

FDG-PET/CT Imaging Predicts Histopathologic Treatment Responses after Neoadjuvant Therapy in Adult Primary Bone Sarcomas
por: Benz, Matthias R., et al.
Publicado: (2010)

Characterizing the immune microenvironment of malignant peripheral nerve sheath tumor by PD-L1 expression and presence of CD8+ tumor infiltrating lymphocytes
por: Shurell, Elizabeth, et al.
Publicado: (2016)

Safety and Efficacy of Stereotactic Body Radiation Therapy in the Treatment of Pulmonary Metastases from High Grade Sarcoma
por: Mehta, Niraj, et al.
Publicado: (2013)

Comprehensive adipocytic and neurogenic tissue microarray analysis of NY-ESO-1 expression - a promising immunotherapy target in malignant peripheral nerve sheath tumor and liposarcoma
por: Shurell, Elizabeth, et al.
Publicado: (2016)

Correction to: Randomized prospective phase III trial of 68Ga-PSMA-11 PET/CT molecular imaging for prostate cancer salvage radiotherapy planning [PSMA-SRT]
por: Calais, Jeremie, et al.
Publicado: (2019)

Gender dimorphism and age of onset in malignant peripheral nerve sheath tumor preclinical models and human patients
por: Shurell, Elizabeth, et al.
Publicado: (2014)

Randomized prospective phase III trial of (68)Ga-PSMA-11 PET/CT molecular imaging for prostate cancer salvage radiotherapy planning [PSMA-SRT]
por: Calais, Jeremie, et al.
Publicado: (2019)

Alveolar Soft Part Sarcomas: Molecular Pathogenesis and Implications for Novel Targeted Therapies
por: Mitton, Bryan, et al.
Publicado: (2012)

Effective molecular targeting of CDK4/6 and IGF-1R in a rare FUS-ERG fusion CDKN2A-deletion doxorubicin-resistant Ewing's sarcoma patient-derived orthotopic xenograft (PDOX) nude-mouse model
por: Murakami, Takashi, et al.
Publicado: (2016)

Tandem Isotope Therapy with (225)Ac- and (177)Lu-PSMA-617 in a Murine Model of Prostate Cancer
por: Meyer, Catherine, et al.
Publicado: (2023)

Correlation of (68)Ga-FAPi-46 PET Biodistribution with FAP Expression by Immunohistochemistry in Patients with Solid Cancers: Interim Analysis of a Prospective Translational Exploratory Study
por: Mona, Christine E., et al.
Publicado: (2022)

Evaluating Thresholds to Adopt Hypofractionated Preoperative Radiotherapy as Standard of Care in Sarcoma
por: Valle, Luca F., et al.
Publicado: (2021)

Use of Denosumab in Children With Osteoclast Bone Dysplasias: Report of Three Cases
por: Upfill‐Brown, Alexander, et al.
Publicado: (2019)

High efficacy of tumor-targeting Salmonella typhimurium A1-R on a doxorubicin- and dactolisib-resistant follicular dendritic-cell sarcoma in a patient-derived orthotopic xenograft PDOX nude mouse model
por: Kiyuna, Tasuku, et al.
Publicado: (2016)

Evaluation of SUV normalized by lean body mass (SUL) in (68)Ga-PSMA11 PET/CT: a bi-centric analysis
por: Gafita, Andrei, et al.
Publicado: (2019)

IGF2BP3 as a Prognostic Biomarker in Well-Differentiated/Dedifferentiated Liposarcoma
por: Klingbeil, Kyle D., et al.
Publicado: (2023)

A novel anionic-phosphate-platinum complex effectively targets an undifferentiated pleomorphic sarcoma better than cisplatinum and doxorubicin in a patient-derived orthotopic xenograft (PDOX)
por: Igarashi, Kentaro, et al.
Publicado: (2017)

Cancer-Associated B Cells in Sarcoma
por: Kendal, Joseph K., et al.
Publicado: (2023)

Tumor-targeting Salmonella typhimurium A1-R regresses an osteosarcoma in a patient-derived xenograft model resistant to a molecular-targeting drug
por: Murakami, Takashi, et al.
Publicado: (2016)

Fibroblastic sarcomas of the mediastinum
por: Chen, Shaoxiong, et al.
Publicado: (2020)

Phase 3 multicenter randomized trial of PSMA PET/CT prior to definitive radiation therapy for unfavorable intermediate-risk or high-risk prostate cancer [PSMA dRT]: study protocol
por: Calais, Jeremie, et al.
Publicado: (2021)

Preclinical evaluation of PSMA expression in response to androgen receptor blockade for theranostics in prostate cancer
por: Lückerath, Katharina, et al.
Publicado: (2018)

Myxoinflammatory Fibroblastic Sarcoma of the Hand
por: Alhumaidan, Mohammed I., et al.
Publicado: (2023)

Recombinant methioninase effectively targets a Ewing's sarcoma in a patient-derived orthotopic xenograft (PDOX) nude-mouse model
por: Murakami, Takashi, et al.
Publicado: (2017)

Evaluation of In Vitro Activity of the Class I PI3K Inhibitor Buparlisib (BKM120) in Pediatric Bone and Soft Tissue Sarcomas
por: Anderson, Jennifer L., et al.
Publicado: (2015)

The Friedman-Eilber Resection Arthroplasty of the Pelvis
por: Schwartz, Adam J., et al.
Publicado: (2009)

Novel Framework for Treatment Response Evaluation Using PSMA PET/CT in Patients with Metastatic Castration-Resistant Prostate Cancer (RECIP 1.0): An International Multicenter Study
por: Gafita, Andrei, et al.
Publicado: (2022)

Effects of novel androgen receptor signaling inhibitors on PSMA PET signal intensity in patients with castrate-resistant prostate cancer: a prospective exploratory serial imaging study
por: Sonni, Ida, et al.
Publicado: (2023)

Recurrent myxoinflammatory fibroblastic sarcoma: a case report
por: Jagadesh, Niveditha, et al.
Publicado: (2017)

Myxoinflammatory Fibroblastic Sarcoma in the Chest Wall
por: Narm, Kyoung Shik, et al.
Publicado: (2012)

Molecular pathogenesis of desmoid tumor and the role of γ-secretase inhibition
por: Federman, Noah
Publicado: (2022)

Cemented Endoprosthetic Reconstruction of the Proximal Tibia: How Long Do They Last?
por: Schwartz, Adam J., et al.
Publicado: (2010)

Cemented Distal Femoral Endoprostheses for Musculoskeletal Tumor: Improved Survival of Modular versus Custom Implants
por: Schwartz, Adam J., et al.
Publicado: (2009)

Chemotherapy and Survival in Patients with Primary High-Grade Extremity and Trunk Soft Tissue Sarcoma
por: Graham, Danielle S., et al.
Publicado: (2020)

A Mobile-Based Mindfulness and Social Support Program for Adolescents and Young Adults With Sarcoma: Development and Pilot Testing
por: Donovan, Elizabeth, et al.
Publicado: (2019)

Ewing Sarcoma/Primitive Neuroectodermal Tumor Involving the Duodenum
por: Tafti, Dawood A., et al.
Publicado: (2022)

THE FUNDAMENTAL PROPERTIES OF THE FIBROBLAST AND THE MACROPHAGE : IV. THE MALIGNANT FIBROBLAST OF JENSEN SARCOMA.
por: Carrel, Alexis, et al.
Publicado: (1928)

Recombinant methioninase combined with doxorubicin (DOX) regresses a DOX-resistant synovial sarcoma in a patient-derived orthotopic xenograft (PDOX) mouse model
por: Igarashi, Kentaro, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_p7ecdgqudgpaigcjpclcr2mtho